REFERENCES
- Awadzi, K., Dadzie, K. Y., Schulz-Key, H., Haddock, D. R. W., Gilles, H. M. & Aziz, M. A. (1985). The chemotherapy of onchocerciasis X. An assessment of four single dose treatment regimens of MK-933 (Ivermectin) in human onchocerciasis. Annals of Tropical Medicine and Parasitology, 79, 63–78.
- Barsby, S. L. (1972). Cost-Benefit Analysis and Manpower Programs. Toronto: Lexington Books.
- Benton, B. & Skinner, E. D. (1990). Cost-benefits of onchocerciasis control. Acta Leidensia, 59, 405–411.
- Bundy, D. A. P. (1990). New initiative in the control of helminths. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84, 457–468.
- Drummond, M. F. (1980). Principles of Economic Appraisal in Health Care. Oxford: Oxford University Press.
- Drummond, M. F. & Mooney, G. (1981). Economic appraisal in health care: a guide to the methodology of economic appraisal. Hospital and Health Services Review, 1, 277–281.
- Greene, B. M., Taylor, H. R., Cupp, E. W., Murphy, R. P., White, A. T., Aziz, M. A., Schutz-Key, H., D'Anna, S. A., Newland, H. S., Goldsmidt, L. P., Auer, C., Hanson, A. P., Freeman, S. V., Reber, E. W. & Williams, P. N. (1985). Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. New England Journal of Medicine, 313, 133–138.
- Klarman, H. E., Francis, J. O. & Rosenthal, G. D. (1968). Cost-effectiveness analysis applied to the treatment of chronic renal disease. Medical Care, 6, 48–54.
- Prost, A. & Prescott, N. (1984). Cost-effectiveness of blindness prevention by the Onchocerciasis Control Programme in Upper Volta. Bulletin of the World Health Organization, 62, 795–802.
- Thomson, J. (1977). Cost-effectiveness of an EMI brain scanner. Health Trends, 9, 16–19.
- White, A. T., Newland, H. S., Taylor, H. R., Ehrmann, K. D., Keyvan-Larijani, E., Nara, A., Aziz, M. A., D'Anna, S. A., Williams, P. N. & Greene, B. M. (1987). Controlled trial and dose-finding study of Ivermectin for treatment of onchocerciasis. Journal of Infectious Diseases, 156, 463–470.